Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Infection with antibiotic-resistant bacteria, such as vancomycin-resistant Enterococcus (VRE), is a dangerous and costly complication of broad-spectrum antibiotic therapy. How antibiotic-mediated elimination of commensal bacteria promotes infection by antibiotic-resistant bacteria is a fertile area for speculation with few defined mechanisms. Here we demonstrate that antibiotic treatment of mice notably downregulates intestinal expression of RegIIIgamma (also known as Reg3g), a secreted C-type lectin that kills Gram-positive bacteria, including VRE. Downregulation of RegIIIgamma markedly decreases in vivo killing of VRE in the intestine of antibiotic-treated mice. Stimulation of intestinal Toll-like receptor 4 by oral administration of lipopolysaccharide re-induces RegIIIgamma, thereby boosting innate immune resistance of antibiotic-treated mice against VRE. Compromised mucosal innate immune defence, as induced by broad-spectrum antibiotic therapy, can be corrected by selectively stimulating mucosal epithelial Toll-like receptors, providing a potential therapeutic approach to reduce colonization and infection by antibiotic-resistant microbes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Colonization resistance takes place through direct (not requiring host involvement) or indirect mechanisms (ultimately mediated by the host response, as mentioned above for the modulation of AMPs) [18, 19].”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [18]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Systemic administration of TLR-5 agonist flagellin, or oral administration of TLR-4 agonist LPS, were shown to reinstate resistance to VRE or C. difficile in mice previously treated with antibiotics, through restoration of RegIII-γ production [18-20].”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [18]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“a defect that can be reverted by oral administration of LPS [18]”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [18]
In the citing paper
“even short-term antibiotic treatment impairs its expression, rendering mice susceptible to vancomycin-resistant enterococcus (VRE) infection”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., & Medzhitov, R. (2004) · Cell · doi:10.1016/j.cell.2004.07.002 · Cited by 4,251
Symbiotic bacteria direct expression of an intestinal bactericidal lectin
Cash, H. L., Whitham, C. V., Behrendt, C. L., & Hooper, L. V. (2006) · Science · doi:10.1126/science.1127119 · Cited by 1,432
Kelly, C. P., Pothoulakis, C., & LaMont, J. T. (1994) · New England Journal of Medicine · doi:10.1056/nejm199401273300406 · Cited by 1,321
Epithelial NEMO links innate immunity to chronic intestinal inflammation
Nenci, A., Becker, C., Wullaert, A., Gareus, R., van Loo, G., Danese, S., Huth, M., Nikolaev, A., Neufert, C., Madison, B., et al. (2007) · Nature · doi:10.1038/nature05698 · Cited by 1,077
Nosocomial Infections in Combined Medical-Surgical Intensive Care Units in the United States
Richards, M. J., Edwards, J. R., Culver, D. H., Gaynes, R. P., & System, N. N. I. S. (2000) · Infection Control & Hospital Epidemiology · doi:10.1086/501795 · Cited by 1,028
Angiogenins: a new class of microbicidal proteins involved in innate immunity
Hooper, L. V., Stappenbeck, T. S., Hong, C. V., & Gordon, J. I. (2003) · Nature Immunology · doi:10.1038/ni888 · Cited by 929
Vancomycin-Resistant Enterococcal Infections
Murray, B. E. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003093421007 · Cited by 890
Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists
Kanzler, H., Barrat, F. J., Hessel, E. M., & Coffman, R. L. (2007) · Nature Medicine · doi:10.1038/nm1589 · Cited by 869
Cario, E., Rosenberg, I. M., Brandwein, S. L., Beck, P. L., Reinecker, H.-C., & Podolsky, D. K. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.966 · Cited by 751
Donskey, C. J., Chowdhry, T. K., Hecker, M. T., Hoyen, C. K., Hanrahan, J. A., Hujer, A. M., Hutton-Thomas, R. A., Whalen, C. C., Bonomo, R. A., & Rice, L. B. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012283432604 · Cited by 689
Cited by
Items 301–400 of 630
Salmonella-induced inflammasome activation in humans
Bierschenk, D., Boucher, D., & Schroder, K. (2016) · Molecular Immunology · doi:10.1016/j.molimm.2016.11.009 · Cited by 48
Microbiota-Based Therapies for Clostridium difficile and Antibiotic-Resistant Enteric Infections
Lewis, B. B., & Pamer, E. G. (2017) · Annual Review of Microbiology · doi:10.1146/annurev-micro-090816-093549 · Cited by 50
Self-citationMultifaceted Defense against Listeria monocytogenes in the Gastro-Intestinal Lumen
Becattini, S., & Pamer, E. G. (2017) · Pathogens · doi:10.3390/pathogens7010001 · Cited by 49
“For instance, production of mucus [72] and anti-microbial peptides [73], modification of conjugated primary bile salts [74], hematopoiesis [75] and functional maturation of immune cells [76], are all heavily influenced by gut commensal bacteria (reviewed in [77]).”
BackgroundSelf-citationCrouzet, L., Derrien, M., Cherbuy, C., Plancade, S., Foulon, M., Chalin, B., Vlieg, J. E. T. V. H., Grompone, G., Rigottier‐Gois, L., & Serror, P. (2018) · Scientific Reports · doi:10.1038/s41598-018-23437-9 · Cited by 48
How Food Affects Colonization Resistance Against Enteropathogenic Bacteria
Kreuzer, M., & Hardt, W. (2020) · Annual Review of Microbiology · doi:10.1146/annurev-micro-020420-013457 · Cited by 49
Enterococci and Their Interactions with the Intestinal Microbiome
Dubin, K. A., & Pamer, E. G. (2018) · ASM Press eBooks · doi:10.1128/9781555819705.ch13 · Cited by 44
Self-citationEnterococci facilitate polymicrobial infections
Xu, W., Fang, Y., & Zhu, K. (2023) · Trends in Microbiology · doi:10.1016/j.tim.2023.07.010 · Cited by 48
Experimental Approaches for Defining Functional Roles of Microbes in the Human Gut
Dantas, G. A., Sommer, M. O. A., Degnan, P. H., & Goodman, A. L. (2013) · Annual Review of Microbiology · doi:10.1146/annurev-micro-092412-155642 · Cited by 49
“Mice treated with a combination of metronidazole, neomycin, and vancomycin were significantly compromised in their ability to clear pathogenic vancomycin-resistant enterococci (9).”
BackgroundFinger, J. W., Thomson, P. C., Adams, A. L., Benedict, S., Moran, C., & Isberg, S. R. (2015) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2015.01.023 · Cited by 43
Gui, X. S., Li, J., Ueno, A., Iacucci, M., Qian, J., & Ghosh, S. (2018) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjy116 · Cited by 54
Jiang, T., Huang, Y., Liu, H., Xu, Q., Gong, Y., Chen, Y., Hu, X., Han, Z., & Gao, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00037 · Cited by 42
“Regenerating islet-derived protein 3-alpha (REG3A), also known as heptocarcinoma–intestine–pancreas or pancreaticassociated protein is a serum biomarker released from the gut upon injury to function as an antimicrobial protein by resisting bacterial proliferation at the injured site (19, 20).”
BackgroundThiemann, S., Smit, N., & Strowig, T. (2016) · Current topics in microbiology and immunology · doi:10.1007/82_2016_504 · Cited by 47
“In mice, antibiotic treatment decreases the expression of regenerating islet-derived protein 3 gamma (RegIIIγ), a potent antimicrobial peptide with anti-VRE activity whose production in Paneth cells is regulated by the commensal microbiota (Brandl et al. 2008).”
BackgroundSoares, F. S., AMARAL, F. C., Silva, N. L. C., Valente, M. R., Santos, L. K. R., Yamashiro, L. H., Scheffer, M. C., Castanheira, F. V. S., Ferreira, R. G., Gehrke, L., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01890 · Cited by 45
“colonization of the small intestine and a predominance of VREs in gut (4, 64).”
BackgroundFouhse, J. M., Yang, K., Juan More, B., Gao, Y., Goruk, S., Plastow, G. S., Field, C. J., Barreda, D. R., & Willing, B. P. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02059 · Cited by 44
“In agreement, exposure of human infants to broad-spectrum antibiotics within 48 h of birth increases Enterobacteriaceae up to 2 months postadministration (51, 52).”
BackgroundInfluentialLisboa, L. F., de Miranda, B. G., Batista, M. V., Dulley, F. L., Fonseca, G. G., Guimarães, T., Levin, A. S., Shikanai‐Yasuda, M. A., & Costa, S. F. (2015) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2015.02.001 · Cited by 40
Benamu, E., & Deresinski, S. C. (2018) · F1000Research · doi:10.12688/f1000research.11831.1 · Cited by 44
“When stimulated via Toll-like receptors by flagella and lipopolysaccharide of GN rods and anaerobes, Paneth cells in the GI tract produce REGIII γ , a C-type lectin with antimicrobial activity against GP bacteria 33,34 .”
BackgroundMicrobiota — an amplifier of autoimmunity
Vogelzang, A., Guerrini, M. M., Minato, N., & Fagarasan, S. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.09.003 · Cited by 41
Yip1 domain family, member 6 (Yipf6) mutation induces spontaneous intestinal inflammation in mice
Brandl, K., Tomisato, W., Li, X., Neppl, C., Pirie, E., Falk, W., Xia, Y., Moresco, E. M. Y., Baccala, R., Theofilopoulos, A. N., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1210366109 · Cited by 40
Self-citationGut microbes and adverse food reactions: Focus on gluten related disorders
Galipeau, H. J., & Verdu, E. F. (2014) · Gut Microbes · doi:10.4161/19490976.2014.969635 · Cited by 44
Djorić, D., Little, J. L., & Kristich, C. J. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02273-19 · Cited by 47
Frisbee, A. L., & Petri, W. A. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.01.009 · Cited by 46
“Antibiotic-mediated downregulation of RegIIIγ leads to reduced killing of Vancomycin Resistant Enterococcus (VRE)[95,96].”
Schubert, M., Rohrbach, R., Schmitt, M. W., & Stein‐Thoeringer, C. K. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.670286 · Cited by 40
Hammad, A. M., & Shimamoto, T. (2010) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2010.04762.x · Cited by 41
“How antibiotic-mediated elimination of commensal bacteria promotes infection by other bacteria is still a fertile area for speculation, with few defined mechanisms (Pamer 2007; Brandl et al. 2008).”
BackgroundDo antibiotics cause mitochondrial and immune cell dysfunction? A literature review
Khpal, M., & Singer, M. (2022) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkac025 · Cited by 43
Emerging Microorganisms and Infectious Diseases: One Health Approach for Health Shared Vision
Ristori, M. V., Guarrasi, V., Soda, P., Petrosillo, N., Gurrieri, F., Longo, U. G., Ciccozzi, M., Riva, E., & Angeletti, S. (2024) · Genes · doi:10.3390/genes15070908 · Cited by 44
“Antimicrobial resistance is pre-dominately present in pathogens isolated from people with a clinically significant infection, but it can reside in organisms isolated from asymptomatic people and can trigger the infection when specific conditions arise as in intestinal inflammation [45].”
BackgroundCouturier-Maillard, A., Froux, N., Piotet, J., Michaudel, C., Brault, L., Bérichel, J. L., Sénéchal, A., Robinet, P., Chenuet, P., Jejou, S., et al. (2018) · Mucosal Immunology · doi:10.1038/s41385-018-0005-8 · Cited by 45
“2b), in accordance with previous studies.(31,45,46) Despite using a unique inoculum for infection, a reduced parasite load was observed in GF mice compared to SPF mice (Fig.”
ResultColonization of the mammalian intestinal tract by enterococci
Banla, L. I., Salzman, N. H., & Kristich, C. J. (2018) · Current Opinion in Microbiology · doi:10.1016/j.mib.2018.10.005 · Cited by 46
Hourigan, D., Stefanovic, E., Hill, C., & Ross, R. P. (2024) · BMC Microbiology · doi:10.1186/s12866-024-03243-2 · Cited by 40
“The introduction of antibiotics causes a decrease in the gram-negative fraction of the microbiota, followed by decreased production of REGIIIγ and the subsequent dominance of VRE in the GIT [210].”
BackgroundMendes, R. E., Woosley, L. N., Farrell, D. J., Sader, H. S., & Jones, R. N. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06067-11 · Cited by 37
“An individual with a compromised mucosal innate immune defense is more prone to bacterial colonization, which eventually progresses to an infectious episode (2).”
BackgroundBacteria and MAMP-induced morphogenesis of the immune system
Eberl, G., & Boneca, I. G. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.06.002 · Cited by 39
Enterococcus Species, Streptococcus gallolyticus Group, and Leuconostoc Species
Arias, C. A., & Murray, B. E. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00202-2 · Cited by 41
Matsukawa, H., Iida, N., Kitamura, K., Terashima, T., Seishima, J., Makino, I., Kannon, T., Hosomichi, K., Yamashita, T., Sakai, Y., et al. (2021) · American Journal of Cancer Research · Cited by 55
Colonization resistance against multi-drug-resistant bacteria: a narrative review
Guern, R. L., Stabler, S., Gosset, P., Pichavant, M., Grandjean, T., Faure, E., Karaca, Y., Faure, K., Kipnis, É., & Dessein, R. (2021) · Journal of Hospital Infection · doi:10.1016/j.jhin.2021.09.001 · Cited by 43
Interactions Between Innate Immunity Genes and Early-Life Risk Factors in Allergic Rhinitis
Seo, J., Kim, H. Y., Jung, Y.-H., Lee, E. M., Yang, S., Yu, H.-S., Kim, Y., Kang, M., Kim, H., Park, K. S., et al. (2015) · Allergy Asthma and Immunology Research · doi:10.4168/aair.2015.7.3.241 · Cited by 40
TREM-1 Promotes Survival during Klebsiella pneumoniae Liver Abscess in Mice
Lin, Y.-T., Tseng, K.-Y., Yeh, Y., Yang, F.-C., Fung, C.-P., & Chen, N. (2014) · Infection and Immunity · doi:10.1128/iai.01347-13 · Cited by 36
Enterococcal bacteremia in mice is prevented by oral administration of probiotic Bacillus spores
Piewngam, P., Chiou, J., Ling, J., Liu, R., Pupa, P., Zheng, Y., & Otto, M. J. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abf4692 · Cited by 36
“faecalis across the gut epithelium Antibiotic therapy can induce depletion of a specific host protein facilitating enterococcal translocation into the bloodstream (20), but the bacterial factors mediating translocation are less well understood.”
Current Knowledge of Th22 Cell and IL-22 Functions in Infectious Diseases
Zhang, K., Chen, L., Zhu, C., Zhang, M., & Liang, C.-Z. (2023) · Pathogens · doi:10.3390/pathogens12020176 · Cited by 31
Novel cancer therapy targeting microbiome
Nagano, T., Otoshi, T., Hazama, D., Kiriu, T., Umezawa, K., Katsurada, N., & Nishimura, Y. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s207546 · Cited by 39
Advances and Prospects in Vaccine Development against Enterococci
Kalfopoulou, E., & Hüebner, J. (2020) · Cells · doi:10.3390/cells9112397 · Cited by 40
“Elimination of the Gram-negative bacteria population using antibiotics decreases REGIIIγ, leading to overgrowth of VRE in the gastrointestinal tract [16,17].”
BackgroundKusakabe, S., Fukushima, K., Yokota, T., Hino, A., Fujita, J., Motooka, D., Nakamura, S., Shibayama, H., & Kanakura, Y. (2020) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2020.01.019 · Cited by 38
Commensal Microbiome Promotes Resistance to Local and Systemic Infections
Zhang, N., & He, Q. (2015) · Chinese Medical Journal · doi:10.4103/0366-6999.162502 · Cited by 41
“typhimurium.[9,10] Similar to Clostridium difficile, VRE is a common cause of antibiotic‐associated diarrhea, which is exceedingly difficult to treat by antibiotics.”
BackgroundNagalingam, N. A., Robinson, C. J., Bergin, I. L., Eaton, K. A., Huffnagle, G. B., & Young, V. B. (2013) · Microbiome · doi:10.1186/2049-2618-1-15 · Cited by 35
Enterococcus Species, Streptococcus bovis Group, and Leuconostoc Species
Arias, C. A., & Murray, B. E. (2010) · Elsevier eBooks · doi:10.1016/b978-0-443-06839-3.00201-0 · Cited by 43
Vancomycin-Resistant E. faecium: Addressing Global and Clinical Challenges
Radford‐Smith, D. E., & Anthony, D. C. (2025) · Antibiotics · doi:10.3390/antibiotics14050522 · Cited by 40
“Harnessing these natural competitive interactions could inform the development of affordable, scalable strategies to prevent or reduce VREfm carriage [97,108].”
Microbial approaches for targeting antibiotic‐resistant bacteria
Wong, W. F., & Santiago, M. (2017) · Microbial Biotechnology · doi:10.1111/1751-7915.12783 · Cited by 34
“For example, some Gram-negative obligate anaerobes are known to induce the production of host antimicrobial peptides (Sonnenburg et al., 2006; Brandl et al., 2008; Kinnebrew et al., 2010; Ubeda et al., 2013).”
BackgroundTransferable vancomycin resistance in clade B commensal-type Enterococcus faecium
Lebreton, F., Valentino, M. D., Schaufler, K., Earl, A. M., Cattoir, V., & Gilmore, M. S. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky039 · Cited by 33
Ziegler, M. J., Han, J., Landsburg, D. J., Pegues, D. A., Reesey, E., Gilmar, C., Gorman, T., Bink, K., Moore, A., & Kelly, B. J. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz252 · Cited by 39
“In conclusion, we found that receipt of levofloxacin for the prophylaxis of neutropenic fever and BSI in patients with hematologic malignancy is associated with lesser disruption of the gut microbiome as compared with receipt of BSBL antibiotics.”
BackgroundInfluentialTao, C., Zhang, Q., Zeng, W., Liu, G., & Shao, H. (2020) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-020-10611-1 · Cited by 33
Alhajjar, N., Chatterjee, A., Spencer, B. L., Burcham, L. R., Willett, J. L. E., Dunny, G. M., Duerkop, B. A., & Doran, K. S. (2020) · Infection and Immunity · doi:10.1128/iai.00270-20 · Cited by 36
“states and during compositional shifts in the host microbiota (47, 48).”
BackgroundKadowaki, T., Yasui, Y., Nishimiya, O., Takahashi, Y., Kohchi, C., Soma, G., & Inagawa, H. (2013) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2013.03.372 · Cited by 34
Bactericidal antibiotic treatment induces damaging inflammation via TLR9 sensing of bacterial DNA
Gross, J. L., Basu, R., Bradfield, C. J., Sun, J., John, S. P., Das, S. B., Dekker, J. P., Weiss, D. S., & Fraser, I. D. C. (2024) · Nature Communications · doi:10.1038/s41467-024-54497-3 · Cited by 34
Wu, Y.-Y., Hsu, C.-M., Chen, P.-H., Fung, C.-P., & Chen, L.-W. (2014) · Infection and Immunity · doi:10.1128/iai.01578-14 · Cited by 32
“It has been shown that expression of RegIII is dependent on TLR-MyD88-mediated signaling in intestinal epithelial cells and is induced by commensal microbes (8).”
BackgroundKobayashi, Y., Inagawa, H., Kohchi, C., Kazumura, K., Tsuchiya, H., Miwa, T., Okazaki, K., & Soma, G. (2018) · PLoS ONE · doi:10.1371/journal.pone.0198493 · Cited by 36
de Medina, F. S., Ortega‐González, M., González-Pérez, R., Capitán‐Cañadas, F., & Martínez‐Augustin, O. (2013) · British Journal Of Nutrition · doi:10.1017/s0007114512004035 · Cited by 36
Anderson, R., Tintinger, G. R., Cockeran, R., Potjo, M., & Feldman, C. H. (2010) · Pharmaceuticals · doi:10.3390/ph3051694 · Cited by 32
Kobayashi, Y., Inagawa, H., Kohchi, C., Kazumura, K., Tsuchiya, H., Miwa, T., Okazaki, K., & Soma, G. (2018) · PLoS ONE · doi:10.1371/journal.pone.0195008 · Cited by 34
Matarazzo, L., Casilag, F., Porte, R., Wallet, F., Cayet, D., Faveeuw, C., Carnoy, C., & Sirard, J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00723 · Cited by 36
Jiang, P., Jensen, M. L., Cilieborg, M. S., Thymann, T., Wan, J. M., Sit, W., Tipoe, G. L., & Sangild, P. T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044929 · Cited by 32
“Regenerating islet-derived protein 3-c (Reg3 c , spot 6009, Table 1 ) is a protein whose expression is triggered by increased microbial-epithelial contact at mucosal surfaces involving activation of TLR–MyD88-mediated signals in small intestine [28,29].”
BackgroundResultIyer, K., Erkert, L., & Becker, C. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1228283 · Cited by 34
“As the production of AMPs requires TLR-dependent stimulation of Paneth cells, an imbalance in the microbiota population has been associated with impaired resistance to bacterial infections (Brandl et al., 2007; Brandl et al., 2008).”
BackgroundEffects of Low-Dose Antibiotics on Gut Immunity and Antibiotic Resistomes in Weaned Piglets
Hu, Q., Liu, C., Zhang, D., Wang, R., Qin, L., Xu, Q., Che, L., & Gao, F. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00903 · Cited by 36
Characterization of the Bacteriophage vB_EfaS-271 Infecting Enterococcus faecalis
Topka, G., Bloch, S., Nejman-Faleńczyk, B., Grabski, M., Jurczak-Kurek, A., Górniak, M., Dydecka, A., Necel, A., Węgrzyn, G., & Węgrzyn, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176345 · Cited by 30
Current View on Major Natural Compounds Endowed with Antibacterial and Antiviral Effects
Arrigoni, R., Ballini, A., Jirillo, E., & Santacroce, L. (2024) · Antibiotics · doi:10.3390/antibiotics13070603 · Cited by 33
Inflammatory bactericidal lectin RegIIIβ: Friend or foe for the host?
Miki, T., Okada, N., & Hardt, W. (2017) · Gut Microbes · doi:10.1080/19490976.2017.1387344 · Cited by 31
“defensive molecule against infection with Gram-positive bacteria such as Listeria monocytogenes and vancomycin resistant Enterococcus (VRE).(6,7) The protective effects are attributable to direct killing of the enteropathogens in the intestinal lumen.”
BackgroundVong, L., Yeung, C. W., Pinnell, L. J., & Sherman, P. M. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000591 · Cited by 31
Brown, C. L., Smith, K., Wall, D. M., & Walker, D. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000488 · Cited by 35
“This is believed to be due to the altered (T cell) immune responses caused by antibiotic-induced changes in the gut flora composition.(54,55) A potential alternative treatment for the correction of dysbiosis is the use of narrow-spectrum antibiotics such as the colicin-like bacteriocins, which demonstrate several high…”
BackgroundSpencer, J. D., Jackson, A. R., Li, B., Ching, C. B., Vonau, M., Easterling, R. S., Schwaderer, A. L., McHugh, K. M., & Becknell, B. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144024 · Cited by 29
“[11,12,13,14,15,16,17] Therefore, in this study we localized RegIIIγ urinary tract expression and assessed its role in uropathogen clearance.”
BackgroundProbiotic Bacteria and Enteric Infections
Paton, A., Morona, R., & Paton, J. (2011) · Springer eBooks · doi:10.1007/978-94-007-0386-5 · Cited by 30
Current status of the microbiome in renal transplantation
Ahmad, S. B., & Bromberg, J. S. (2016) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000262 · Cited by 30
“At homeostasis, bacterial products stimulate production of mucus, bactericidal molecules, and biofilms by IECto exclude pathogenic bacteria and promote colonization by commensal bacteria [19,20].”
BackgroundBanla, I. L., Kommineni, S., Hayward, M., Rodrigues, M., Palmer, K. L., Salzman, N. H., & Kristich, C. J. (2017) · Infection and Immunity · doi:10.1128/iai.00381-17 · Cited by 33
“This colonization resistance is achieved directly through competition and indirectly through modulation of innate immune defenses (3, 34, 35), suggesting that nutrient acquisition and resistance to both microbe- and host-produced antimicrobials are important for successful colonization.”
BackgroundTwo Strains of Lactobacilli Effectively Decrease the Colonization of VRE in a Mouse Model
Li, X., Song, L., Zhu, S., Xiao, Y., Huang, Y., Hua, Y., Chu, Q., & Ren, Z. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00006 · Cited by 29
Luther, M. K., Rice, L. B., & LaPlante, K. L. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03126-15 · Cited by 31
“Both gut anaerobes and Gram-negative bacteria interact with VRE growth and the immune regulation of VRE (34, 35).”
BackgroundAdaptation of Candida albicans During Gastrointestinal Tract Colonization
Mishra, A. A., & Koh, A. Y. (2018) · Current Clinical Microbiology Reports · doi:10.1007/s40588-018-0096-8 · Cited by 26
What we need to know about the germ-free animal models
Aghighi, F., & Salami, M. (2024) · AIMS Microbiology · doi:10.3934/microbiol.2024007 · Cited by 33
Almyroudis, N. G., Lesse, A. J., Hahn, T., Samonis, G., Hazamy, P. A., Wongkittiroch, K., Wang, E. S., McCarthy, P. L., Wetzler, M., & Segal, B. H. (2011) · Infection Control and Hospital Epidemiology · doi:10.1086/659408 · Cited by 26
“Variables: Median time from admission to last VRE screen Median time from admission to VRE colonization Length of hospital stay Antibiotics: Patients who received one or more antibiotics during their hospital admission (%) Patient-days on any antibiotic Intravenous vancomycin Ceftazidime Piperacillin-tazobactam Carbap…”
BackgroundGut colonization with vancomycin-resistant Enterococcus and risk for subsequent enteric infection
Axelrad, J. E., Lebwohl, B., Cuaresma, E., Cadwell, K., Green, P. H. R., & Freedberg, D. E. (2018) · Gut Pathogens · doi:10.1186/s13099-018-0259-4 · Cited by 27
Dharmaratne, P., Rahman, N., Leung, A., & Ip, M. (2021) · Annals of Medicine · doi:10.1080/07853890.2021.1927170 · Cited by 29
“pneumoniae compared to VRE, indicating their high permeability towards the mucus layer, during the weak expression of host antimicrobial molecules such as RegIIIc upon pre-antibiotic treatment [79].”
BackgroundWeisser, M., Oostdijk, E. A. N., Willems, R. J. L., Bonten, M. J. M., Frei, R., Elzi, L., Halter, J. P., Widmer, A. F., & Top, J. (2012) · BMC Infectious Diseases · doi:10.1186/1471-2334-12-68 · Cited by 26
“In this study all patients in ICU received SOD, an oral antibiotic-containing paste, which may promote colonization in ARE [25,26].”
MethodRosa, S. L. L., Casey, P. G., Hill, C., Diep, D. B., Nes, I. F., & Brede, D. A. (2013) · Applied and Environmental Microbiology · doi:10.1128/aem.00831-13 · Cited by 30
“However, it is consistent with the requirements for further predisposing factors, such as immunocompromised hosts (47), also reported to occur as a consequence of the use of specific types of antibiotics such as vancomycin (29, 46).”
BackgroundKong, M., Zhao, W., Wang, C., Qi, J., Liu, J., & Zhang, Q. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105525 · Cited by 27
“Based on previous relevant studies on zebrafish, vancomycin, metronidazole, neomycin sulfate, and ampicillin were used to deplete intestinal bacteria in T. ovatus [16,49].”
BackgroundHarnessing the human gut microbiota: an emerging frontier in combatting multidrug-resistant bacteria
Ding, W., Cheng, Y., Liu, X., Zhu, Z., Wu, L., Gao, J., Lei, W., Li, Y., Zhou, X., Wu, J., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1563450 · Cited by 30
van der Heijden, K. M., van der Heijden, I. M., Galvão, F. H. F., Lopes, C. G., Costa, S. F., Abdala, E., D′Albuquerque, L. A. C., & Levin, A. S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108453 · Cited by 26
“The use of broad spectrum antimicrobials has been shown in experimental studies to be a predisposing factor in itself for translocation of vancomycin-resistant enterococci [30,31].”
BackgroundScorzoni, L., de Menezes, R. T., Pereira, T. C., OLIVEIRA, P. S., Ribeiro, F. D. C., Santos, E. L. D. S., Fugisaki, L. R. D. O., OLIVEIRA, L. D. D., & Amorim, J. B. O. (2020) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765202020200703 · Cited by 26
Structural and Functional Features of a Developmentally Regulated Lipopolysaccharide-Binding Protein
Krasity, B. C., Troll, J. V., Lehnert, E. M., Hackett, K. T., Dillard, J. P., Apicella, M. A., Goldman, W. E., Weiss, J. P., & McFall‐Ngai, M. (2015) · mBio · doi:10.1128/mbio.01193-15 · Cited by 26
“However, the expression of the gene encoding RegIII is induced by the presence of Gramnegative bacteria or LPS (47, 48).”
BackgroundRashidi, A., & Weisdorf, D. J. (2020) · Translational research · doi:10.1016/j.trsl.2020.03.011 · Cited by 26
Goulding, D. R., Myers, P., Dickerson, A. B., Comins, M. M., Wiltshire, R. A., & Blankenship-Paris, T. L. (2021) · Comparative Medicine · doi:10.30802/aalas-cm-21-000023 · Cited by 24
“A significant difference in water consumption (F (2,7) = 93.”
BackgroundThe immune response and antibacterial therapy
Anuforom, O., Wallace, G. R., & Piddock, L. J. V. (2014) · Medical Microbiology and Immunology · doi:10.1007/s00430-014-0355-0 · Cited by 32
“These data suggest that mucosal resistance to bacteria can be enhanced by agents that boost mucosal immunity [57, 58].”
BackgroundThe gut microbiota and host immunity synergistically orchestrate colonization resistance
Li, N., & Guo, X. (2026) · Gut Microbes · doi:10.1080/19490976.2025.2611545 · Cited by 28
“12 Consistently, MYD88-deficient mice exhibit compromised intestinal barrier function and significantly elevated pathogen burdens following C. rodentium infection, highlighting the essential role of TLR-MYD88 signaling in maintaining colonization resistance.”
Qian, J., Hu, Y., Zhao, L., Xia, J., Li, C., Shi, L., & Xu, F. (2016) · Stem Cells · doi:10.1002/stem.2337 · Cited by 26
Raising the Alarmone: Within-Host Evolution of Antibiotic-Tolerant Enterococcus faecium
Tyne, D. V., & Gilmore, M. S. (2017) · mBio · doi:10.1128/mbio.00066-17 · Cited by 23
Harris, V. (2018) · Drugs · doi:10.1007/s40265-018-0941-3 · Cited by 25
Comparative Antimicrobial Activity of Hp404 Peptide and Its Analogs against Acinetobacter baumannii
Hong, M. J., Kim, M. K., & Park, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115540 · Cited by 23
Bacterial Pneumonia and Lung Abscess
Torres, A., Menéndez, R., & Wunderink, R. G. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-3383-5.00033-6 · Cited by 33
Chen, C.-P., & Wickstrom, E. (2010) · Bioconjugate Chemistry · doi:10.1021/bc100136e · Cited by 23
Role of nutrition, infection, and the microbiota in the efficacy of oral vaccines
Bhattacharjee, A., & Hand, T. W. (2018) · Clinical Science · doi:10.1042/cs20171106 · Cited by 22
Zhang, C., Peng, Y., Mu, C., & Zhu, W. (2018) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-018-0265-x · Cited by 22
“Discussion Previous studies have shown that oral antibiotics may cause gut microbiota dysbiosis, suppress the innate immune defenses, and lead to the increased pathogen colonization and disease susceptibility in mice [18, 28, 29].”
A Modern-World View of Host–Microbiota–Pathogen Interactions
Tan, C. Y., Ramirez, Z. E., & Surana, N. K. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2100215 · Cited by 24
Sarker, P., Mily, A., Mamun, A., Jalal, S., Bergman, P., Raqib, R., Gudmundsson, G. H., & Agerberth, B. (2014) · Antibiotics · doi:10.3390/antibiotics3030353 · Cited by 25
“Moreover, in a previous study, down-regulation of the antimicrobial protein RegIIIγ in the small intestinal mucosa of antibiotic-treated mice was shown to increase the colonization of gut by vancomycin-resistant Enterococcus [48].”
ResultSala, P., Torrinhas, R. S., Fonseca, D. C., Machado, N. M., Singer, J., Singer, P., Ravacci, G. R., Belarmino, G., Ferreira, B. D. A. M., Marques, M. Q., et al. (2020) · Nutrition · doi:10.1016/j.nut.2020.110885 · Cited by 21
Effect of major abdominal surgery on the host immune response to infection
Buttenschoen, K., Fathimani, K., & Buttenschoen, D. C. (2010) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e32833939cb · Cited by 30
Reciprocal Expression of Enteric Antimicrobial Proteins in Intestinal Graft-Versus-Host Disease
Eriguchi, Y., Uryu, H., Nakamura, K., Shimoji, S., Takashima, S., Iwasaki, H., Miyamoto, T., Shimono, N., Hashimoto, D., Akashi, K., et al. (2013) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2013.07.027 · Cited by 25
“These results are consistent with previous studies demonstrating that RegIIIγ expression is controlled by microorganism-associated molecular patterns that activate MyD88 pathway in non-hematopoietic cells in steady state and in bacterial infection(12-15, 17).”
BackgroundMethodResultInfluential
Metadata
- Authors
- Brandl, K., Plitas, G., Mihu, C. N., Ubeda, C., Jia, T., Fleisher, M., Schnabl, B., DeMatteo, R. P., & Pamer, E. G.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- University of California San Diego (US)
- Corresponding author
- Pamer, Eric G.
- Venue
- Nature
- Published
- 2008-08-24
- Volume
- 455
- Issue
- 7214
- Pages
- 804-807
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC2663337
- OpenAlex
- W2093972125
- Cited by
- 631
- References
- 28
- Citations by year
- 2026: 14 · 2025: 28 · 2024: 27 · 2023: 30 · 2022: 25 · 2021: 29 · 2020: 48 · 2019: 32 · 2018: 56 · 2017: 41 · 2016: 36 · 2015: 39 · 2014: 37 · 2013: 38 · 2012: 39
- FWCI
- 15.24
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Alexander von Humboldt-Stiftung
- National Institutes of Health (4r37ai039031-21)
- National Institute of Allergy and Infectious Diseases (AI42135, R01AI039031, R01AI080619, R37-AI039031, AI 39031, R01AI042135)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Life Sciences › Immunology and Microbiology › Microbiology › Antimicrobial Peptides and Activities
- Keywords
- vancomycin-resistant enterococci, antibiotic resistance, intestinal innate immunity, RegIIIγ, C-type lectin, broad-spectrum antibiotics, TLR4, lipopolysaccharide, mucosal epithelium, commensal bacteria, antibiotic-associated infection, Gram-positive bacteria
- MeSH terms
- Pancreatitis-Associated Proteins, Animals, Immunity, Innate, Intestinal Mucosa, Intestines, Lipopolysaccharides, Proteins, Vancomycin, Signal Transduction, Down-Regulation, Enterococcus, Vancomycin Resistance, Toll-Like Receptor 4, Mice, Myeloid Differentiation Factor 88
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.